- Title
- Xanthine oxidase inhibitors in heart failure: where do we go from here?
- Creators
- Leonardo Tamariz - From Department of Medicine (L.T., J.M.H.) and Interdisciplinary Stem Cell Institute (J.M.H.), University of Miami Miller School of Medicine, FL; and Veterans Affairs Medical Center, Miami, FL (L.T.)Joshua M Hare - From Department of Medicine (L.T., J.M.H.) and Interdisciplinary Stem Cell Institute (J.M.H.), University of Miami Miller School of Medicine, FL; and Veterans Affairs Medical Center, Miami, FL (L.T.). jhare@med.miami.edu
- Publication Details
- Circulation (New York, N.Y.), Vol.131(20), pp.1741-1744
- Publisher
- United States
- Grant note
- R01 HL110737 / NHLBI NIH HHS R01 HL107110 / NHLBI NIH HHS R01 HL084275 / NHLBI NIH HHS R01HL084275 / NHLBI NIH HHS UM1 HL113460 / NHLBI NIH HHS 5UMHL113460 / PHS HHS
- Academic Unit
- Leadership Department; Miller School of Medicine; Interdisciplinary Stem Cell Institute; UMMG Department of Medicine
- Language
- English
- Resource Type
- Journal article
- PMID
- 25986446
- PMCID
- PMC4438774
- Record Identifier
- 991031559381602976
Journal article
Xanthine oxidase inhibitors in heart failure: where do we go from here?
Circulation (New York, N.Y.), Vol.131(20), pp.1741-1744
2015-05-19
PMCID: PMC4438774
PMID: 25986446
Metrics
10 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.281 Auto-inflammatory Diseases
- 1.281.1192 Gout
- Web Of Science research areas
- Cardiac & Cardiovascular Systems
- Peripheral Vascular Disease
- ESI research areas
- Clinical Medicine
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites